Integrating cilta-cel into earlier lines of therapy: Rationale and latest data from CARTITUDE-2 and CARTITUDE-4
Here we summarize the rationale and latest clinical trial data investigating the use of cilta-cel in earlier lines of therapy in multiple myeloma.